Read + Share
Gao L, Ramirez FJ, Cabrera JTO, Varghese MV, et al. eNAMPT is a novel therapeutic target for mitigation of coronary microvascular
disease in type 2 diabetes. Diabetologia 2024 Jun 19. doi: 10.1007/s00125-024-06201.
PMID: 38898303
|
 |
|
Gao L, Ramirez FJ, Cabrera JTO, Varghese MV, et al. eNAMPT is a novel therapeutic target for mitigation of coronary microvascular
disease in type 2 diabetes. Diabetologia 2024 Jun 19. doi: 10.1007/s00125-024-06201.
PMID: 38898303
|
|
|
|